News

June 18, 2024

Ability Biologics Announces the Closing of its US $18 Million Seed Funding Extension toward the Generation of Novel, Highly Targeted Immunomodulators

DownloadPDF - 338.67KB
December 6, 2023

Ability Biologics Unveils Discovery Platform that Generates Antibodies with Unparalleled Specificity and Selectivity

DownloadPDF - 641.70KB